Prescription / clinicalClassification unresolvedConflict flaggedApproved and compounded pathways18 documented products
Lovely Meds
The catalog documents 18 current products from Lovely Meds, with 5 usable public prices. Access begins through online questionnaire, and the catalog was last checked Aug 18, 2026.
Products are shown once even when a blend contains several tracked components. Each card distinguishes flat all-dose pricing, dose-dependent pricing, and starting-price-only offers so a low entry price is not mistaken for a high-dose price. Dose and strength details are provider-stated catalog information, not dosing advice.
Buy Wegovy® Online in USA
Weight loss & metabolic healthCampaign price may differFDA-approved product accessSemaglutide
The product page lists $1,603.33 per month, while a campaign page lists $370.00. A lower promotional price may be available, but its eligibility and terms may differ.
Current cost
From $1,603.33/month total
Price behavior
Starting price only
Subscription
No separate subscription
Certificate of analysis
Not applicable to this offer
Available dosage / strength
Branded weekly semaglutide injection; provider describes 0. 25 mg initiation and 2. 4 mg maintenance plus unpriced multi-month bundles.
$370 per week provider-listed; approximately $1,603.33 per calendar month for ranking only.
Current provider pages list $90.00 and $150.00 and $235.00 per month. A lower price may be available; confirm eligibility and the final price with the provider.
Compounded tirzepatide+B12 subcutaneous multidose-vial kit with syringes; numeric vial strength and volume are not public. Longer one-time plans ship every three months.
Dose or option
Supply
Current price
Source
1 month — current provider discrepancy
Compounded tirzepatide+B12 subcutaneous multidose-vial kit with syringes; numeric vial strength and volume are not public. Longer one-time plans ship every three months.
$235.00 per month (higher provider price shown; provider also lists $90.00 or $150.00)
Compounded tirzepatide+B12 subcutaneous multidose-vial kit with syringes; numeric vial strength and volume are not public. Longer one-time plans ship every three months.
$597.00 per program package (higher provider price shown; provider also lists $199.00)
Compounded tirzepatide+B12 subcutaneous multidose-vial kit with syringes; numeric vial strength and volume are not public. Longer one-time plans ship every three months.
$1,050.00 per program package (higher provider price shown; provider also lists $175.00)
Compounded tirzepatide+B12 subcutaneous multidose-vial kit with syringes; numeric vial strength and volume are not public. Longer one-time plans ship every three months.
$1,800.00 per program package (higher provider price shown; provider also lists $150.00)
Daily oral tablet sold as a one-time full-course pack; strength, count and duration are not public. Current body copy no longer reproduces the prior troche conflict.
Once-daily topical 3-in-1 scalp foam with GHK-Cu peptide, finasteride and latanoprost; numeric component strengths, volume and duration are not public.
Personalized lower-than-standard compounded GLP-1 protocol; the title names semaglutide/tirzepatide while detailed copy repeatedly describes only semaglutide, and route/strength/package are not public.
One marketed NAD+ parent with explicit injection, nasal-spray and topical face-cream route variants; strength, quantity, duration and price are not public for any route.
Dose or option
Supply
Current price
Source
NAD+ Injection
NAD+ injection route variant; strength and package are not public.
Once-daily oral semaglutide liquid measured by oral syringe, held sublingually for 30–60 seconds, then swallowed; strength and bottle volume are not public.
Current provider copy conflicts among sublingual drops/liquid measured by oral syringe, a compounded troche, and once-daily swallowing with water; strength, volume and count are not public.
Compounded semaglutide+B12 subcutaneous injection; prescribed strength and vial volume vary and are not public. One-, three-, six- and twelve-month one-time plan labels are current.
Dose or option
Supply
Current price
Source
1 month — current acquisition conflict
Compounded semaglutide+B12 subcutaneous injection; prescribed strength and vial volume vary and are not public. One-, three-, six- and twelve-month one-time plan labels are current.
$175.00 per month (higher provider price shown; provider also lists $39.00)
Compounded semaglutide+B12 subcutaneous injection; prescribed strength and vial volume vary and are not public. One-, three-, six- and twelve-month one-time plan labels are current.
Compounded semaglutide+B12 subcutaneous injection; prescribed strength and vial volume vary and are not public. One-, three-, six- and twelve-month one-time plan labels are current.